Management of Severe Asthma, CTS,
Seasonal Respiratory Virus Vaccines in Immunocompromised Patients, IDSA,
Drug Hypersensitivity Skin Testing: Methods and Non-Irritative Concentrations, EAACI,
Nomenclature of Immune-Mediated Drug Reactions, EAACI,
Precautionary Allergen Labelling: International Consensus, WAO,
Biologic Therapies for Chronic Rhinosinusitis With Nasal Polyps, BRS,
2026 Asthma Management and Prevention: Summary Guide, GINA,
Surgical Management of Non-Allergic Rhinitis, EAACI,
Pollen Exposure and Respiratory Allergy: Prevention and Public Health, EAACI,
Diagnosis of GLILD in Common Variable Immunodeficiency, ESID/ERS,
Difficult-to-Treat and Severe Asthma: Diagnosis and Management, GINA,
JAK Inhibitors for Inborn Errors of JAK–STAT Signalling, ESID/EBMT-IEWP/ERN-RITA,
Stem Cell Transplantation for Inborn Errors of Immunity and Metabolism, EBMT/ESID,
Cardiac Involvement in Eosinophilia, ESC,
Global Strategy for Asthma Management and Prevention, GINA,
Hypersensitivity to Drug Excipients, EAACI,
Management of Atopic Dermatitis in Children and Adolescents, AAD,
Penicillin Allergy in Pregnancy, SMFM,
ARIA–EAACI: Oral and Ocular Treatments for Allergic Rhinitis, ARIA/EAACI,
Classification, Diagnosis and Treatment of Hereditary Angioedema, WAO,
Autoimmune Blistering Diseases in Children and Adolescents, EADV,
Non-Biological and RNA-Based Therapies for Chronic Inflammatory Diseases, EAACI,
Definition, Classification, Diagnosis and Management of Urticaria, GA²LEN/EuroGuiDerm/APAAACI/AAD/BSACI/GAAACI,
Comorbid Chronic Rhinosinusitis and Asthma, EAACI,
Treatment of NSAID-Exacerbated Respiratory Disease, EAACI,
Olfactory Testing in Inflammatory Upper Airway Disorders, EAACI,
Digital and Sustainable Transformation in Allergy Care, EAACI,
Diagnosis and Management of VEXAS Syndrome, ACR,
Management of Familial Mediterranean Fever, EULAR/PReS,
